Cystic Fibrosis: A Review of Associated Phenotypes, Use of Molecular Diagnostic Approaches, Genetic Characteristics, Progress, and Dilemmas

Journal of Molecular Diagnostics

Volumn 18, Issue 1, 2016, Pages 3-14

  Brennan, Marie Luise ^a   Schrijver, Iris ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR PROTEIN, HUMAN;

ALLELE; CHORION VILLUS SAMPLING; CLINICAL LABORATORY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DNA MODIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HERITABILITY; HUMAN; LABORATORY TEST; LIFE EXPECTANCY; METABOLIC SYNDROME X; MOLECULAR DIAGNOSIS; NEWBORN SCREENING; NUTRITIONAL STATUS; PHENOTYPE; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; REVIEW; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MOLECULAR PATHOLOGY; MUTATION; NEWBORN; PROCEDURES;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT, NEWBORN; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; NEONATAL SCREENING; PATHOLOGY, MOLECULAR; PRENATAL DIAGNOSIS;

EID: 84954065827     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2015.06.010     Document Type: Review

References (69)

1. Welsh MJ, Ramsey BW, Accurso F, Cutting GR: Cystic fibrosis. Metabolic and Molecular Bases of Inherited Disease, 8th Edition, Volume 3. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York, McGraw-Hill, 2013, pp 5121-5188
2. G.E. Palomaki, S.C. FitzSimmons, and J.E. Haddow Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population Genet Med 6 2004 405 414
3. Katkin JP, Schultz K. Cystic fibrosis: overview of gastrointestinal disease in UpToDate, Post TW (Ed), In UpToDate [Internet]. Copyright Wolters Kluwer, Waltham, MA. Available at http://www.uptodate.com/contents/cystic-fibrosis-overview-of-gastrointestinal-disease, last revised July 15, 2015
4. N. Pillarisetti, E. Williamson, B. Linnane, B. Skoric, C.F. Robertson, P. Robinson, J. Massie, G.L. Hall, P. Sly, S. Stick, S. Ranganathan Australian Respiratory Early Surveillance Team for Cystic Fibrosis Infection, inflammation, and lung function decline in infants with cystic fibrosis Am J Respir Crit Care Med 184 2011 75 81
5. Cystic Fibrosis Foundation Patient Registry: Annual Data Report to the Center Directors. Bethesda, MD, 2011
6. P.M. Farrell, B.J. Rosenstein, T.B. White, F.J. Accurso, C. Castellani, G.R. Cutting, P.R. Durie, V.A. Legrys, J. Massie, R.B. Parad, M.J. Rock, and P.W. Campbell Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report J Pediatr 153 2008 S4 S14
7. D. Borowitz, R.B. Parad, J.K. Sharp, K.A. Sabadosa, K.A. Robinson, M.J. Rock, P.M. Farrell, M.K. Sontag, M. Rosenfeld, S.D. Davis, B.C. Marshall, and F.J. Accurso Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond J Pediatr 155 2009 S106 S116
8. J.D. Groman, M.E. Meyer, R.W. Wilmott, P.L. Zeitlin, and G.R. Cutting Variant cystic fibrosis phenotypes in the absence of CFTR mutations N Engl J Med 347 2002 401 407
9. S.J. Mayell, A. Munck, J.V. Craig, I. Sermet, K.G. Brownlee, M.J. Schwarz, C. Castellani, K.W. Southern European Cystic Fibrosis Society Neonatal Screening Working Group A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis J Cyst Fibros 8 2009 71 78
10. R.V. Lebo, and W.W. Grody Testing and reporting ACMG cystic fibrosis mutation panel results Genet Test 11 2007 11 31
11. M.S. Watson, G.R. Cutting, R.J. Desnick, D.A. Driscoll, K. Klinger, M. Mennuti, G.E. Palomaki, B.W. Popovich, V.M. Pratt, E.M. Rohlfs, C.M. Strom, C.S. Richards, D.R. Witt, and W.W. Grody Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel Genet Med 6 2004 387 391
12. American College of Obstetrics, Gynecologists Committee on Genetics ACOG Committee Opinion No. 486: update on carrier screening for cystic fibrosis Obstet Gynecol 117 2011 1028 1031
13. W.W. Grody, G.R. Cutting, K.W. Klinger, C.S. Richards, M.S. Watson, R.J. Desnick Subcommittee on Cystic Fibrosis Screening Accreditation of Genetic Services Committee, ACMG, American College of Medical Genetics Laboratory standards and guidelines for population-based cystic fibrosis carrier screening Genet Med 3 2001 149 154
14. Delatycki M, Burke J, Cristie L, Collines F, Gabbet M, George P, Haan E, Ioannou L, Massie J, McKenzie F, O'Leary P, Scoble-Williams N, Turner G, Human Genetics Society of Australia Genetic Services Committee. [Internet] Position statement. Population based carrier screening for cystic fibrosis. Copyright Human Genetics Society of Australasia, Sydney, Australia. Available at documents/item/1282, last revised October 2013
15. C. Castellani, M. Macek Jr., J.J. Cassiman, A. Duff, J. Massie, L.P. ten Kate, D. Barton, G. Cutting, B. Dallapiccola, E. Dequeker, E. Girodon, W. Grody, E.W. Highsmith, H. Kaariainen, S. Kruip, M. Morris, P.F. Pignatti, U. Pypops, M. Schwarz, M. Soller, M. Stuhrman, and H. Cuppens Benchmarks for cystic fibrosis carrier screening: a European consensus document J Cyst Fibros 9 2010 165 178
16. W.W. Grody, B.H. Thompson, A.R. Gregg, L.H. Bean, K.G. Monaghan, A. Schneider, and R.V. Lebo ACMG position statement on prenatal/preconception expanded carrier screening Genet Med 15 2013 482 483
17. K.G. Monaghan, W.E. Highsmith, J. Amos, V.M. Pratt, B. Roa, M. Friez, L.L. Pike-Buchanan, I.M. Buyse, J.B. Redman, C.M. Strom, A.L. Young, and W. Sun Genotype-phenotype correlation and frequency of the 3199del6 cystic fibrosis mutation among I148T carriers: results from a collaborative study Genet Med 6 2004 421 425
18. E. Langfelder-Schwind, B. Karczeski, M.N. Strecker, J. Redman, E.A. Sugarman, C. Zaleski, T. Brown, S. Keiles, A. Powers, S. Ghate, and R. Darrah Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors J Genet Couns 23 2014 5 15
19. S. Ogino, R.B. Wilson, B. Gold, P. Hawley, and W.W. Grody Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening Genet Med 6 2004 439 449
20. W.W. Grody, G.R. Cutting, and M.S. Watson The Cystic Fibrosis mutation "arms race": when less is more Genet Med 9 2007 739 744
21. A.B. Zinn Inborn errors of metabolism A.A. Fanaroff, R.J. Martin, Neonatal-Perinatal Medicine ed 7 2002 Mosby St Louis 1468
22. S.D. Grosse, C.A. Boyle, J.R. Botkin, A.M. Comeau, M. Kharrazi, M. Rosenfeld, B.S. Wilfond CDC Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs MMWR Recomm Rep 53 2004 1 36
23. J.S. Wagener, E.T. Zemanick, and M.K. Sontag Newborn screening for cystic fibrosis Curr Opin Pediatr 24 2012 329 335
24. A. Deucher, and I. Schrijver Newborn screening for cystic fibrosis. Cystic Fibrosis: Etiology, Diagnosis and Treatments 2009 Nova Science Publishers Inc. Hauppauge, NY 1 28
25. M.J. Rock, E.H. Mischler, P.M. Farrell, W.T. Bruns, D.J. Hassemer, and R.H. Laessig Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test Pediatr Pulmonol 6 1989 42 48
26. O. Sommerburg, V. Krulisova, J. Hammermann, M. Lindner, M. Stahl, M. Muckenthaler, D. Kohlmueller, M. Happich, A.E. Kulozik, F. Votava, M. Balascakova, V. Skalicka, M. Stopsack, M. Gahr, M. Macek Jr., M.A. Mall, and G.F. Hoffmann Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations J Cyst Fibros 13 2014 15 23
27. J.L. Bobadilla, M. Macek Jr., J.P. Fine, and P.M. Farrell Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening Hum Mutat 19 2002 575 606
28. M.H. Farrell, and P.M. Farrell Newborn screening for cystic fibrosis: ensuring more good than harm J Pediatr 143 2003 707 712
29. R. Padoan, S. Genoni, E. Moretti, M. Seia, A. Giunta, and C. Corbetta Genetic and clinical features of false-negative infants in a neonatal screening programme for cystic fibrosis Acta Paediatr 91 2002 82 87
30. L. Narzi, M. Lucarelli, A. Lelli, F. Grandoni, S. Lo Cicero, A. Ferraro, P. Matarazzo, I. Delaroche, S. Quattrucci, R. Strom, and M. Antonelli Comparison of two different protocols of neonatal screening for cystic fibrosis Clin Genet 62 2002 245 249
31. A.M. Comeau, R.B. Parad, H.L. Dorkin, M. Dovey, R. Gerstle, K. Haver, A. Lapey, B.P. O'Sullivan, D.A. Waltz, R.G. Zwerdling, and R.B. Eaton Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections Pediatrics 113 2004 1573 1581
32. V. Krulisova, M. Balascakova, V. Skalicka, T. Piskackova, A. Holubova, J. Paderova, P. Krenkova, L. Dvorakova, D. Zemkova, P. Kracmar, B. Chovancova, V. Vavrova, A. Stambergova, F. Votava, and M. Macek Jr. Prospective and parallel assessments of cystic fibrosis newborn screening protocols in the Czech Republic: IRT/DNA/IRT versus IRT/PAP and IRT/PAP/DNA Eur J Pediatr 171 2012 1223 1229
33. C.Y. Ooi, A. Dupuis, L. Ellis, K. Jarvi, S. Martin, T. Gonska, R. Dorfman, P. Kortan, M. Solomon, E. Tullis, and P.R. Durie Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language? Thorax 67 2012 618 624
34. K. De Boeck, M. Wilschanski, C. Castellani, C. Taylor, H. Cuppens, J. Dodge, M. Sinaasappel Diagnostic Working Group Cystic fibrosis: terminology and diagnostic algorithms Thorax 61 2006 627 635
35. H.C. Chan, X. Jiang, and Y.C. Ruan Emerging role of cystic fibrosis transmembrane conductance regulator as an epigenetic regulator: linking environmental cues to microRNAs Clin Exp Pharmacol Physiol 41 2014 615 622
36. C.S. Richards, L.A. Bradley, J. Amos, B. Allitto, W.W. Grody, A. Maddalena, M.J. McGinnis, T.W. Prior, B.W. Popovich, M.S. Watson, and G.E. Palomaki Standards and guidelines for CFTR mutation testing Genet Med 4 2002 379 391
37. C.S. Richards, S. Bale, D.B. Bellissimo, S. Das, W.W. Grody, M.R. Hegde, E. Lyon, B.E. Ward Molecular Subcommittee of the ALQAC ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007 Genet Med 10 2008 294 300
38. H.L. Rehm, S.J. Bale, P. Bayrak-Toydemir, J.S. Berg, K.K. Brown, J.L. Deignan, M.J. Friez, B.H. Funke, M.R. Hegde, E. Lyon Working Group of the American College of Medical Genetics, Genomics Laboratory Quality Assurance Committee ACMG clinical laboratory standards for next-generation sequencing Genet Med 15 2013 733 747
39. I. Schrijver, N. Aziz, D.H. Farkas, M. Furtado, A. Ferreira-Gonzalez, T.C. Greiner, W.W. Grody, T. Hambuch, L. Kalman, J.A. Kant, R.D. Klein, D.G.B. Leonard, I.M. Lubin, R. Mao, N. Nagan, V.M. Pratt, M.E. Sobel, K.V. Voelkerding, and J.S. Gibson Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology J Mol Diagn 14 2012 525 540
40. V.M. Pratt, M. Caggana, C. Bridges, A.M. Buller, L. DiAntonio, W.E. Highsmith, L.M. Holtegaard, K. Muralidharan, E.M. Rohlfs, J. Tarleton, L. Toji, S.D. Barker, and L.V. Kalman Development of genomic reference materials for cystic fibrosis genetic testing J Mol Diagn 11 2009 186 193
41. N. Aziz, Q. Zhao, L. Bry, D.K. Driscoll, B. Funke, J.S. Gibson, W.W. Grody, M.R. Hegde, G.A. Hoeltge, D.G. Leonard, J.D. Merker, R. Nagarajan, L.A. Palicki, R.S. Robetorye, I. Schrijver, K.E. Weck, and K.V. Voelkerding College of American Pathologists' Laboratory Standards for Next-Generation Sequencing Clinical Tests Arch Pathol Lab Med 11 2015 186 193
42. E. Lyon, I. Schrijver, K.E. Weck, A. Ferreira-Gonzalez, C.S. Richards, and G.E. Palomaki Molecular genetic testing for cystic fibrosis: laboratory performance on the College of American Pathologists external proficiency surveys Genet Med 17 2015 219 225
43. C.S. Richards, G.E. Palomaki, F.L. Lacbawan, E. Lyon, G.L. Feldman CAP/ACMG Biochemical and Molecular Genetics Resource Committee Three-year experience of a CAP/ACMG methods-based external proficiency testing program for laboratories offering DNA sequencing for rare inherited disorders Genet Med 16 2014 25 32
44. M.N. Hurley, T.M. McKeever, A.P. Prayle, A.W. Fogarty, and A.R. Smyth Rate of improvement of CF life expectancy exceeds that of general population: observational death registration study J Cyst Fibros 13 2014 410 415
45. S.M. Rowe, and A.S. Verkman Cystic fibrosis transmembrane regulator correctors and potentiators Cold Spring Harb Perspect Med 3 2013 10.1101/cshperspect.a009761 pii: a009761
46. J.W. Hanrahan, H.M. Sampson, and D.Y. Thomas Novel pharmacological strategies to treat cystic fibrosis Trends Pharmacol Sci 34 2013 119 125
47. J.P. Clancy, and M. Jain Personalized medicine in cystic fibrosis: dawning of a new era Am J Respir Crit Care Med 186 2012 593 597
48. D.R. Gill, and S.C. Hyde Delivery of genes into the CF airway Thorax 69 2014 962 964
49. S.H. Donaldson, and L. Galietta New pulmonary therapies directed at targets other than CFTR Cold Spring Harb Perspect Med 3 2013 10.1101/cshperspect.a009787 pii: a009787
50. P.R. Sosnay, K.R. Siklosi, F. Van Goor, K. Kaniecki, H. Yu, N. Sharma, A.S. Ramalho, M.D. Amaral, R. Dorfman, J. Zielenski, D.L. Masica, R. Karchin, L. Millen, P.J. Thomas, G.P. Patrinos, M. Corey, M.H. Lewis, J.M. Rommens, C. Castellani, C.M. Penland, and G.R. Cutting Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene Nat Genet 45 2013 1160 1167
51. S.M. Rowe, S. Miller, and E.J. Sorscher Cystic fibrosis N Engl J Med 352 2005 1992 2001
52. C.Y. Ooi, R. Dorfman, M. Cipolli, T. Gonska, C. Castellani, K. Keenan, S.D. Freedman, J. Zielenski, Y. Berthiaume, M. Corey, S. Schibli, E. Tullis, and P.R. Durie Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis Gastroenterology 140 2011 153 161
53. S.M. Blackman, R. Deering-Brose, R. McWilliams, K. Naughton, B. Coleman, T. Lai, M. Algire, S. Beck, J. Hoover-Fong, A. Hamosh, M.D. Fallin, K. West, D.E. Arking, A. Chakravarti, D.J. Cutler, and G.R. Cutting Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis Gastroenterology 131 2006 1030 1039
54. A.I. Adler, B.S. Shine, P. Chamnan, C.S. Haworth, and D. Bilton Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults Diabetes Care 31 2008 1789 1794
55. M.R. Knowles, and M. Drumm The influence of genetics on cystic fibrosis phenotypes Cold Spring Harb Perspect Med 2 2012 a009548 10.1101/cshperspect.a009548
56. R.V. Lebo, and W.W. Grody Variable penetrance and expressivity of the splice altering 5T sequence in the cystic fibrosis gene Genet Test 11 2007 32 44
57. F. Stanke, T. Becker, V. Kumar, S. Hedtfeld, C. Becker, H. Cuppens, S. Tamm, J. Yarden, U. Laabs, B. Siebert, L. Fernandez, M. Macek Jr., D. Radojkovic, M. Ballmann, J. Greipel, J.J. Cassiman, T.F. Wienker, and B. Tummler Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia J Med Genet 48 2011 24 31
58. L.L. Vanscoy, S.M. Blackman, J.M. Collaco, A. Bowers, T. Lai, K. Naughton, M. Algire, R. McWilliams, S. Beck, J. Hoover-Fong, A. Hamosh, D. Cutler, and G.R. Cutting Heritability of lung disease severity in cystic fibrosis Am J Respir Crit Care Med 175 2007 1036 1043
59. M.J. Emond, T. Louie, J. Emerson, W. Zhao, R.A. Mathias, M.R. Knowles, F.A. Wright, M.J. Rieder, H.K. Tabor, D.A. Nickerson, K.C. Barnes National Heart Lung, Blood Institute GO Exome Sequencing Project G.O. Lung, R.L. Gibson, and M.J. Bamshad Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis Nat Genet 44 2012 886 889
60. G.R. Cutting Modifier genes in Mendelian disorders: the example of cystic fibrosis Ann N Y Acad Sci 1214 2010 57 69
61. J.M. Collaco, S.M. Blackman, J. McGready, K.M. Naughton, and G.R. Cutting Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function J Pediatr 157 2010 802 807
62. F.A. Wright, L.J. Strug, V.K. Doshi, C.W. Commander, S.M. Blackman, L. Sun, and et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2 Nat Genet 43 2011 539 546
63. J. Davies, E. Alton, and U. Griesenbach Cystic fibrosis modifier genes J R Soc Med 98 Suppl 45 2005 47 54
64. J.M. Collaco, and G.R. Cutting Update on gene modifiers in cystic fibrosis Curr Opin Pulm Med 14 2008 559 566
65. L. Sun, J.M. Rommens, H. Corvol, W. Li, X. Li, T.A. Chiang, F. Lin, R. Dorfman, P.F. Busson, R.V. Parekh, D. Zelenika, S.M. Blackman, M. Corey, V.K. Doshi, L. Henderson, K.M. Naughton, W.K. O'Neal, R.G. Pace, J.R. Stonebraker, S.D. Wood, F.A. Wright, J. Zielenski, A. Clement, M.L. Drumm, P.Y. Boelle, G.R. Cutting, M.R. Knowles, P.R. Durie, and L.J. Strug Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis Nat Genet 44 2012 562 569
66. W. Li, D. Soave, M.R. Miller, K. Keenan, F. Lin, J. Gong, T. Chiang, A.L. Stephenson, P. Durie, J. Rommens, L. Sun, and L.J. Strug Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities Hum Genet 133 2014 151 161
67. S.M. Blackman, C.W. Commander, C. Watson, K.M. Arcara, L.J. Strug, J.R. Stonebraker, F.A. Wright, J.M. Rommens, L. Sun, R.G. Pace, S.A. Norris, P.R. Durie, M.L. Drumm, M.R. Knowles, and G.R. Cutting Genetic modifiers of cystic fibrosis-related diabetes Diabetes 62 2013 3627 3635
68. G.M. Bradley, S.M. Blackman, C.P. Watson, V.K. Doshi, and G.R. Cutting Genetic modifiers of nutritional status in cystic fibrosis Am J Clin Nutr 96 2012 1299 1308
69. J.R. Bartlett, K.J. Friedman, S.C. Ling, R.G. Pace, S.C. Bell, B. Bourke, G. Castaldo, C. Castellani, M. Cipolli, C. Colombo, J.L. Colombo, D. Debray, A. Fernandez, F. Lacaille, M. Macek Jr., M. Rowland, F. Salvatore, C.J. Taylor, C. Wainwright, M. Wilschanski, D. Zemkova, W.B. Hannah, M.J. Phillips, M. Corey, J. Zielenski, R. Dorfman, Y. Wang, F. Zou, L.M. Silverman, M.L. Drumm, F.A. Wright, E.M. Lange, P.R. Durie, M.R. Knowles Gene Modifier Study Group Genetic modifiers of liver disease in cystic fibrosis JAMA 302 2009 1076 1083